• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO VASCULAR SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO VASCULAR SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK ABSOLUTE PRO
Device Problems Break (1069); Difficult to Remove (1528); Stretched (1601); Material Deformation (2976); Activation Failure (3270); Migration (4003)
Patient Problems Obstruction/Occlusion (2422); Device Embedded In Tissue or Plaque (3165)
Event Date 01/16/2024
Event Type  Injury  
Event Description
It was reported that the procedure was performed to treat a heavily calcified target lesion in the superficial femoral artery (sfa), with intended stenting locations in the distal, mid and proximal sfa.The patient anatomy included high-grade stenosis in the ipsilateral sfa due to a sclerosed unspecified vascular plug in the distal sfa.On the contralateral side, there was vascular calcification in the pelvic inlet without limitation of wire probing.A 6french crossover sheath was used and the first absolute pro self-expanding stent system (sess) was advanced to the distal sfa.Deployment was initiated; however, the stent only partially deployed, although there was no reported issue with the thumbwheel, and was caught on the vascular plug.During removal of the delivery system, the stent fully deployed, as it remained caught on the vascular plug.The stent was deemed not possible to retrieve and remains in the patient anatomy.The second absolute pro sess was advanced to the target lesion and deployment was initiated; however, during deployment, difficulty was noted with the final release and a complete loss of mesh structure occurred.The stent fissured [break] and stretched three times its length.The stent migrated and became embedded in the pelvic circulation, completely outside the target lesion.The stent was unable to be retrieved and occluded the vessel.Balloon angioplasty was performed as treatment of the occlusion.A third absolute pro sess was advanced to the target lesion; however, the stent could not be deployed, although there was no reported issue with the thumbwheel.There was no adverse patient sequela.No additional information was provided.
 
Manufacturer Narrative
D4: the udi number is not known as the part and lot number were not provided.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.The additional absolute pro device referenced in b5 is filed under separate medwatch report number.
 
Manufacturer Narrative
The device was not returned for analysis.Electronic lot history record (elhr) and exception reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot level product quality issue.The reported patient effects of occlusion and intervention due to stent migration, unintentional placement of stent, partial stent deployment, stretched and/or damaged stents are listed in the absolute pro.035 peripheral self-expanding stent system instructions for use as adverse events that may be associated with the use of a stent in peripheral arteries and/or biliary tree: as there was no damage noted to the device during the inspection prior to use, it is possible that the distal shaft was bent in the heavily calcified anatomy resulting in preventing the shaft lumens from moving freely; thus resulting in the reported activation/deployment difficulties; however this cannot be confirmed.The investigation determined a conclusive cause for the reported activation/deployment difficulties cannot be determined.During removal of the delivery system interaction with the vascular plug resulted in the reported difficult to remove.Interaction/manipulation of the compromised device resulted in the stent to heavily stretch/deform, migrate, and ultimately break.As reported, the stent migrated and became embedded in the pelvic circulation.The stent was unable to be retrieved and occluded.The reported difficulties possibly caused/contributed to the reported patient effects; however a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The treatments appears to be related to the operational context of the procedure as balloon angioplasty was performed as treatment of the occlusion.Based on the reported information and results of the complaint investigation there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
Subsequent to the initial report, additional information was received.It was reported the first absolute pro stent heavily stretched yet was retrieved with a retrieval catheter.The second 6.0 x 100mm absolute pro stent caught on the unspecified vascular plug, causing a complete loss of mesh structure to occur.The third absolute pro stent was deployed at the target lesion with no issues.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO VASCULAR SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18669318
MDR Text Key334948858
Report Number2024168-2024-01599
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K072708
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/08/2024
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received02/08/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK ABSOLUTE PRO
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/01/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/07/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6F CROSSOVER SHEATH; ABSOLUTE PRO; UNSPECIFIED VASCULAR PLUG
Patient Outcome(s) Required Intervention;
-
-